KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Shares Outstanding (Diluted Average) (2020 - 2025)

Twist Bioscience (TWST) has disclosed Shares Outstanding (Diluted Average) for 4 consecutive years, with $57.0 million as the latest value for Q2 2023.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 7.61% to $57.0 million in Q2 2023 year-over-year; TTM through Jun 2023 was $57.0 million, a 7.61% increase, with the full-year FY2022 number at $53.9 million, up 11.68% from a year prior.
  • Shares Outstanding (Diluted Average) was $57.0 million for Q2 2023 at Twist Bioscience, roughly flat from $56.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $57.0 million in Q2 2023 to a low of $39.2 million in Q3 2020.
  • A 4-year average of $51.4 million and a median of $53.0 million in 2022 define the central range for Shares Outstanding (Diluted Average).
  • Peak YoY movement for Shares Outstanding (Diluted Average): grew 23.12% in 2021, then rose 6.18% in 2023.
  • Twist Bioscience's Shares Outstanding (Diluted Average) stood at $39.2 million in 2020, then grew by 27.36% to $49.9 million in 2021, then increased by 13.09% to $56.4 million in 2022, then increased by 1.06% to $57.0 million in 2023.
  • Per Business Quant, the three most recent readings for TWST's Shares Outstanding (Diluted Average) are $57.0 million (Q2 2023), $56.8 million (Q1 2023), and $56.4 million (Q4 2022).